BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 27853027)

  • 1. Cluster endophthalmitis following multiple intravitreal bevacizumab injections from a single use vial.
    Khan P; Khan L; Mondal P
    Indian J Ophthalmol; 2016 Sep; 64(9):694-696. PubMed ID: 27853027
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Beri S; Shandil A; Garg R
    Indian J Ophthalmol; 2017 Nov; 65(11):1166-1171. PubMed ID: 29133644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management and Visual Outcomes of Acute Bacterial Endophthalmitis Following Intravitreal Injection of Contaminated Bevacizumab in a Single Day.
    Xu K; Mousa R; Loewenstein A; Barak A; Chin EK; Almeida DRP
    Ophthalmic Surg Lasers Imaging Retina; 2020 Jun; 51(6):346-352. PubMed ID: 32579693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute bilateral endophthalmitis following bilateral intravitreal bevacizumab (avastin) injection.
    Tabatabaii A; Ahmadraji A; Khodabande A; Mansouri M
    Middle East Afr J Ophthalmol; 2013; 20(1):87-8. PubMed ID: 23580860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of Endophthalmitis after Intravitreal Anti-vascular Endothelial Growth Factor: Experience in Saudi Arabia.
    Al-Rashaed S; Alsulaiman SM; Alrushood AA; Almasaud J; Arevalo JF
    Middle East Afr J Ophthalmol; 2016; 23(1):60-3. PubMed ID: 26957840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal bevacizumab: safety of multiple doses from a single vial for consecutive patients.
    Ng DS; Kwok AK; Chan CW; Li WW
    Hong Kong Med J; 2012 Dec; 18(6):488-95. PubMed ID: 23223649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bilateral same-day intravitreal injections using a single vial and molecular bacterial screening for safety surveillance.
    Woo SJ; Han JM; Ahn J; Heo JW; Yu HG; Chung H; Song J; Park KU; Park KH
    Retina; 2012 Apr; 32(4):667-71. PubMed ID: 22307220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents.
    Shah CP; Garg SJ; Vander JF; Brown GC; Kaiser RS; Haller JA;
    Ophthalmology; 2011 Oct; 118(10):2028-34. PubMed ID: 21705087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An outbreak of streptococcus endophthalmitis after intravitreal injection of bevacizumab.
    Goldberg RA; Flynn HW; Isom RF; Miller D; Gonzalez S
    Am J Ophthalmol; 2012 Feb; 153(2):204-208.e1. PubMed ID: 22264943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of compounded bevacizumab with postinjection endophthalmitis.
    VanderBeek BL; Bonaffini SG; Ma L
    JAMA Ophthalmol; 2015 Oct; 133(10):1159-64. PubMed ID: 26270251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal injections at the Massachusetts Eye and Ear Infirmary: analysis of treatment indications and postinjection endophthalmitis rates.
    Englander M; Chen TC; Paschalis EI; Miller JW; Kim IK
    Br J Ophthalmol; 2013 Apr; 97(4):460-5. PubMed ID: 23390167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic antibiotic use after intravitreal injection: effect on endophthalmitis rate.
    Bhatt SS; Stepien KE; Joshi K
    Retina; 2011 Nov; 31(10):2032-6. PubMed ID: 21659941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COMPARATIVE RISK OF ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION WITH BEVACIZUMAB, AFLIBERCEPT, AND RANIBIZUMAB.
    Bavinger JC; Yu Y; VanderBeek BL
    Retina; 2019 Oct; 39(10):2004-2011. PubMed ID: 30312260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Extemporaneous withdrawal with a mini-spike filter: A low infection risk technique for drawing up bevacizumab for intravitreal injection].
    Le Rouic JF; Breger D; Peronnet P; Hermouet-Leclair E; Alphandari A; Pousset-Decré C; Badat I; Becquet F
    J Fr Ophtalmol; 2016 May; 39(5):415-20. PubMed ID: 27155911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-intravitreal injection endophthalmitis secondary to Turicella otitidis: a case report.
    Mammo DA; Watson D; Armbrust KR
    BMC Ophthalmol; 2020 Apr; 20(1):142. PubMed ID: 32276621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute intraocular inflammation caused by endotoxin after intravitreal injection of counterfeit bevacizumab in Shanghai, China.
    Wang F; Yu S; Liu K; Chen FE; Song Z; Zhang X; Xu X; Sun X
    Ophthalmology; 2013 Feb; 120(2):355-61. PubMed ID: 23084126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacillus cereus endophthalmitis following intravitreous bevacizumab injection.
    Kopel AC; Carvounis PE; Holz ER
    Ophthalmic Surg Lasers Imaging; 2008; 39(2):153-4. PubMed ID: 18435343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of topical antibiotic prophylaxis to prevent endophthalmitis after intravitreal injection.
    Storey P; Dollin M; Pitcher J; Reddy S; Vojtko J; Vander J; Hsu J; Garg SJ;
    Ophthalmology; 2014 Jan; 121(1):283-289. PubMed ID: 24144453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Large Outbreak of Fulminant Bacterial Endophthalmitis after Intravitreal Injection of Counterfeit Bevacizumab.
    Entezari M; Karimi S; Ahmadieh H; Mahmoudi AH; Parhizgar H; Yaseri M
    Graefes Arch Clin Exp Ophthalmol; 2016 Sep; 254(9):1851-6. PubMed ID: 27377655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An outbreak of fungal endophthalmitis after intravitreal injection of compounded combined bevacizumab and triamcinolone.
    Sheyman AT; Cohen BZ; Friedman AH; Ackert JM
    JAMA Ophthalmol; 2013 Jul; 131(7):864-9. PubMed ID: 23640384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.